<DOC>
	<DOCNO>NCT02838199</DOCNO>
	<brief_summary>The purpose study determine Transcatheter aortic valve replacement ( TAVR ) SAPIEN 3 superior traditional surgical aortic valve replacement ( SAVR ) bio-prosthesis regard rate all-cause mortality 1 year patient symptomatic severe aortic valve stenosis .</brief_summary>
	<brief_title>TRANscatheter SurgIcal Aortic Valve ReplacemenT All-Comers With Severe Aortic Valve Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Age must least 19 less 75 year old Severe aortic valve stenosis echocardiographically derive criterion : mean gradient &gt; 40mmHg jet velocity great 4.0 m/s AND initial aortic valve area ( AVA ) â‰¤ 0.8 cm2 . Echocardiogram must within 3 month date procedure Patient symptomatic his/her aortic valve stenosis , demonstrate NYHA class II great . The patient guardian agrees study protocol schedule clinical angiographic followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site . Life expectancy &lt; 1 year due medical illness Suspected Malignancy Inoperability evaluate surgeon Concomitant severe coronary artery disease amenable percutaneous coronary intervention Concomitant severe mitral valve significant aorta disease require surgery Active bacterial endocarditis within 6 month procedure Leukopenia ( WBC &lt; 3000 cell/mL ) , acute anemia ( Hgb &lt; 8g/dL ) , thrombocytopenia ( platelet &lt; 50000 cell/mL ) Intracardiac thrombus A known contraindication hypersensitivity anticoagulation regimen , inability anticoagulated study procedure . Native aortic annulus size &lt; 18 mm &gt; 25 mm measure echocardiogram . Expectation patient improve despite treatment aortic stenosis Patients actively participate another drug device investigational study , complete primary endpoint followup period .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Transcatheter aortic valve replacement</keyword>
	<keyword>TAVR</keyword>
	<keyword>TAVI</keyword>
	<keyword>SAVR</keyword>
</DOC>